The China Securities Regulatory Commission has approved Lin Ping Development's application for an IPO listing on the Shanghai Stock Exchange.
On December 31st, the China Securities Regulatory Commission issued the "Approval for Anhui Linping Circular Development Co., Ltd.'s Initial Public Offering of Shares".
On December 31, the China Securities Regulatory Commission issued the "Approval for the Initial Public Offering of Shares of Anhui Linping Circular Development Co., Ltd." It is reported that Linping Development plans to list on the main board of the Shanghai Stock Exchange, with Guolian Minsheng Securities as its sponsor, and plans to raise 1.2 billion yuan.
According to the prospectus, Linping Development is mainly engaged in the research and development, production, and sales of corrugated paper and box board paper products. It is a high-tech enterprise with independent research and innovation capabilities. After years of development, the company has grown into a comprehensive resource utilization enterprise integrating waste paper utilization, cogeneration of heat and power, and green papermaking. The company has always valued environmental protection, energy conservation and emission reduction, and has achieved resource recycling and sustainable development through processes such as waste paper utilization, sewage treatment, reuse of white water and middle water, biogas combustion for power generation, sludge reuse, cogeneration of heat and power, and green manufacturing.
The company's main products include corrugated paper and box board paper, which are sold to downstream manufacturers for the production of corrugated paper boxes, widely used in the fields of logistics transportation, industrial products, and consumer goods packaging.
Related Articles

ZHONGZHIPHARM(03737) issues a profit warning, expecting a decrease in annual net profit of no less than 70%.

SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer

RIMAG GROUP (02522) has issued 6.13 million H shares of bonus shares.
ZHONGZHIPHARM(03737) issues a profit warning, expecting a decrease in annual net profit of no less than 70%.

SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer

RIMAG GROUP (02522) has issued 6.13 million H shares of bonus shares.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


